Why To Keep Buying Caladrius Biosciences Inc. (NASDAQ:CLBS) while S&P500 loss -0.15%
Caladrius Biosciences Inc. (NASDAQ:CLBS) previous close was $1.58 while the outstanding shares total 59.50M. The firm has a beta of 1.06. CLBS’s shares traded higher